Venus Remedies Limited — Vancomycin Exporter Profile
Indian Pharmaceutical Exporter · #9 for Vancomycin · $2.2M export value · DGFT Verified
Venus Remedies Limited is the #9 Indian exporter of Vancomycin with $2.2M in export value and 113 verified shipments. Venus Remedies Limited holds a 2.4% market share in Vancomycin exports across 19 countries. The company exports 29 pharmaceutical products worth $86.4M across 6 therapeutic categories.
Venus Remedies Limited — Vancomycin Export Profile: Buyers & Destinations
Where Does Venus Remedies Limited Export Vancomycin?
| Country | Value | Shipments | Share |
|---|---|---|---|
| IRAQ | $420.0K | 11 | 24.8% |
| DOMINICAN REPULIC | $281.8K | 16 | 16.6% |
| PHILIPPINES | $195.2K | 12 | 11.5% |
| DOMINICAN REPUBLIC | $163.1K | 6 | 9.6% |
| YEMEN | $136.3K | 3 | 8.0% |
| YEMEN DEMOCRATIC | $101.1K | 5 | 6.0% |
| YEMEN, DEMOCRATIC | $68.6K | 2 | 4.0% |
| OMAN | $62.4K | 11 | 3.7% |
| LEBANON | $55.8K | 8 | 3.3% |
| LIBYAN ARAB REPUBLIC | $38.2K | 6 | 2.3% |
Venus Remedies Limited exports Vancomycin to 22 countries. The largest destination is IRAQ accounting for 24.8% of Venus Remedies Limited's Vancomycin shipments, followed by DOMINICAN REPULIC (16.6%) and PHILIPPINES (11.5%). These destinations reflect Venus Remedies Limited's established distribution network and regulatory approvals in key markets.
Who Are the Top Buyers of Vancomycin from Venus Remedies Limited?
| Buyer | Country | Value | Orders |
|---|---|---|---|
| P C F P I | IRAQ | $320.0K | 9 |
| P T | DOMINICAN REPUBLIC | $225.5K | 10 |
| M/S PHARMACEUTICAL TECHNOLOGY | DOMINICAN REPULIC | $114.6K | 8 |
| A I B | YEMEN | $86.3K | 2 |
| A P D C | PHILIPPINES | $82.4K | 4 |
| TO THE ORDER OF | YEMEN, DEMOCRATIC | $68.6K | 2 |
| PHARMACEUTICAL TECHNOLOGY | DOMINICAN REPULIC | $67.2K | 3 |
| B P D & C C | PHILIPPINES | $56.2K | 5 |
| T B S | YEMEN DEMOCRATIC | $54.0K | 2 |
| TO TADHAMON BANK | YEMEN | $50.0K | 1 |
Venus Remedies Limited supplies Vancomycin to 47 buyers globally. The largest buyer is P C F P I (IRAQ), followed by P T (DOMINICAN REPUBLIC) and M/S PHARMACEUTICAL TECHNOLOGY (DOMINICAN REPULIC). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.
What Is India's Total Vancomycin Export Value and How Much Does Venus Remedies Limited Contribute?
India exported $58.7M worth of Vancomycin through 3,071 shipments from 318 suppliers to 140 countries, serving 743 buyers globally. Venus Remedies Limited contributes $2.2M to this total, accounting for 2.4% of India's Vancomycin exports. Venus Remedies Limited ships Vancomycin to 22 countries through 47 buyers.
What Is the Average Shipment Value for Venus Remedies Limited's Vancomycin Exports?
Venus Remedies Limited's average Vancomycin shipment value is $19.4K per consignment, based on 113 shipments totaling $2.2M. The largest destination is IRAQ (24.8% of Venus Remedies Limited's Vancomycin exports).
How Does Venus Remedies Limited Compare to Other Indian Vancomycin Exporters?
Venus Remedies Limited ranks #9 among 318 Indian Vancomycin exporters with a 2.4% market share. The top 3 exporters are MYLAN LABORATORIES LIMITED ($15.9M), STRIDES PHARMA SCIENCE LIMITED ($11.0M), GLAND PHARMA LIMITED ($5.4M). Venus Remedies Limited processed 113 shipments to 19 destination countries.
What Vancomycin Formulations Does Venus Remedies Limited Export?
| Product Description / Formulation | Value | Shipments |
|---|---|---|
| VANCOMYCIN HYDROCHLORIDE FOR INJ. USP 1000 MG (MOOWR SCHEME VIDE LICENSE NO.- 03/2023 -LUDHIANA)NOS | $146.6K | 3 |
| VANCOMYCIN HYDROCHLORIDE FOR INJ USP 100 | $116.1K | 5 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION U | $98.9K | 9 |
| VANCOMYCIN HYDROCHLORIDE FOR INJ. USP 1000 MG E. VIAL CONT:VANCOMYCIN HYDROCHLORIDE U.S.P. EQV. TO VANCOMYCIN...1000 MGVLS | $63.3K | 3 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP 1000MG EACH VIAL CONT VANCOMYCIN HYDROCHLORIDE U S P EQV TO VANCOMYCIN 1000MG | $50.0K | 1 |
| VANCOMYCIN HYDROCHLORIDE FOR INJ USP 1000 MG E VIAL CONT VANCOMYCIN HCL U S P EQV TO VANCOMYCIN 1000 MG | $50.0K | 1 |
| VANCONEX CP 1.0 GM VANCOMYCIN HYDROCHLORIDE FOR INJECTION U.S.PBATCH NO.X3JVA052A MANUFACTURING .DT.10/2023EXP.DT.09/2025 | $50.0K | 1 |
| VANCOMYCIN HYDROCHLORIDE FOR INJ. USP 1000 MG E. VIAL CONT:VANCOMYCIN HYDROCHLORIDE U.S.P. EQV. TO VANCOMYCIN...1000 MG | $50.0K | 1 |
| VANCOMYCIN HYDROCHLORIDE FOR INJ. USP1000 MG.VANCOMYCIN 1.0 GM.B.NO.X4BVA022A,X4BVA032A,X4BVA042A,MD.02/24 ED.01/26 | $50.0K | 1 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION USP 1000 MG (VALEPTA 1GM) B.NO.X5BVA022FMD.02/2025 EXP.DT.01/2027 | $50.0K | 1 |
Venus Remedies Limited exports 87 distinct Vancomycin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is VANCOMYCIN HYDROCHLORIDE FOR INJ. USP 1000 MG (MOOWR SCHEME with 3 shipments worth $146.6K.
How Does Venus Remedies Limited Compare to Nearest Vancomycin Exporters?
Exporters ranked immediately above and below #9 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | GLAND PHARMA LTD | $3.0M | 59 | 7 | $50.0K |
| 8 | LUPIN LIMITED | $2.5M | 49 | 1 | $50.0K |
| 9 | VENUS REMEDIES LIMITED ★ | $2.2M | 113 | 19 | $19.4K |
| 4 | EUGIA PHARMA SPECIALITIES LIMITED | $2.0M | 40 | 1 | $50.0K |
| 10 | LYKA LABS LIMITED | $1.4M | 36 | 7 | $37.9K |
Venus Remedies Limited ranks #9 among 318 Indian Vancomycin exporters. Average shipment value of $19.4K compared to the market average of $184.6K. The closest competitors by value are GLAND PHARMA LTD and LUPIN LIMITED.
Which Indian Ports Ship Vancomycin Exports?
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR | 406 | 13.2% |
| SAHAR AIR CARGO ACC (INBOM4) | 395 | 12.9% |
| NHAVA SHEVA SEA (INNSA1) | 221 | 7.2% |
| DELHI AIR | 135 | 4.4% |
| BANGALORE ACC (INBLR4) | 134 | 4.4% |
| BANGALORE AIR | 133 | 4.3% |
| BANGALORE ICD (INWFD6) | 119 | 3.9% |
| HYDERABAD ACC (INHYD4) | 116 | 3.8% |
Geopolitical & Trade Policy Impact on Venus Remedies Limited's Vancomycin Exports
The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Venus Remedies. The ongoing Israel-Iran tensions have led to disruptions in Red Sea shipping routes, increasing transit times and costs for exports to Europe and the Americas. Such disruptions necessitate strategic adjustments in logistics and supply chain management to maintain timely deliveries and cost-effectiveness.
Conversely, the U.S.-China trade tensions have opened avenues for Indian pharmaceutical companies to strengthen their presence in the U.S. market. India now supplies 40% of the U.S.'s generic drug needs, reflecting a growing reliance on Indian manufacturers. (ibef.org) Venus Remedies' recent QIDP designation from the U.S. FDA for VRP-034 positions the company favorably to leverage this opportunity, potentially enhancing its market share in the U.S.
In the European Union, compliance with the Falsified Medicines Directive (FMD) remains critical. Venus Remedies' renewal of the EU-GMP certification indicates their proactive approach to meeting stringent EU regulations, thereby ensuring continued access to European markets. (business-standard.com)
Venus Remedies Limited — Regulatory Compliance & Quality Standards
Maintaining compliance with international regulatory standards is paramount for pharmaceutical exporters. Venus Remedies has demonstrated a consistent commitment to quality, as evidenced by multiple GMP certifications. In addition to the EU-GMP renewal, the company secured GMP certification from Moldova's Ministry of Health in January 2025, covering their antibiotic-carbapenem manufacturing facility. (apnnews.com) Furthermore, the renewal of Ukrainian GMP certification in May 2025 for their Baddi facility underscores their adherence to global quality standards. (apnnews.com)
These certifications not only facilitate market access but also enhance the company's reputation as a reliable supplier of high-quality pharmaceuticals. In an industry where regulatory compliance is closely scrutinized, Venus Remedies' proactive measures position them favorably among global competitors.
About Venus Remedies Limited
Venus Remedies Limited exports 29 products worth $86.4M. Beyond Vancomycin, top products include Meropenem, Imipenem, Enoxaparin, Ceftriaxone, Paclitaxel. View the complete Venus Remedies Limited profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Vancomycin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- CDSCO India
- Pharmexcil
- IBEF — India Pharma Industry
- Ministry of Commerce — Pharma Exports
- India Trade Statistics (DGFT)
Verify manufacturer licensing and export certifications with the official agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Vancomycin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
- 2.Supplier Identification: Venus Remedies Limited matched across shipments using name normalization, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
- 4.Verified Records: This page is backed by 116 individual customs records matching Venus Remedies Limited exporting Vancomycin, covering 87 formulations to 22 countries via 47 buyers.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 140+ countries, 743+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Vancomycin Export Data from Venus Remedies Limited
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Venus Remedies Limited's Vancomycin exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Venus Remedies Limited
Full Company Profile →
29 products · $86.4M total trade · 6 categories
Vancomycin Stats
Company Overview
Top Products by Venus Remedies Limited
Related Analysis
Need Detailed Export Data?
Access shipment-level records, pricing trends, and buyer contacts for Venus Remedies Limited.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Vancomycin. For current shipment-level data, contact TransData Nexus.